RxDoctor Payments Data

Emily Roach, NP

Nurse Practitioner · West Frankfort, ILNPI 1811579287

Payments from drug & device makers

$923in general payments, 2019–2025

Across 54 payments — averaging $17.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$186
  • Johnson & Johnson$167
  • AstraZeneca$116
  • Bayer$80
  • AbbVie$59
  • Upsher-smith Laboratories LLC$51
  • plus $265 from 9 others

What the payments were for

  • Food & beverage$923100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$923 in reported general payments places this provider in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$13,339
Medicare patients
87
Services billed
260

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$45,880
JardianceEmpagliflozin31$19,335
VraylarCariprazine Hcl11$15,110
MounjaroTirzepatide14$14,138
TrulicityDulaglutide13$12,907
RybelsusSemaglutide14$12,742
OzempicSemaglutide13$12,509
XareltoRivaroxaban15$7,942
JanumetSitagliptin Phos/Metformin Hcl13$6,770
FarxigaDapagliflozin Propanediol11$6,084
TrintellixVortioxetine Hydrobromide12$5,974
Spiriva HandihalerTiotropium Bromide11$5,351
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen196$4,187
Febuxostat13$2,603
Gabapentin156$1,983

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$186$27,04527 claims
Novo NordiskRybelsus, Ozempic$45$25,25127 claims
AbbVieVraylar, Synthroid$59$16,55840 claims
Johnson & JohnsonXarelto$167$7,94215 claims
AstraZenecaFarxiga$116$6,08411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in West Frankfort

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →